Zhimin Zeng

Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study

Jiong Cai, Anwen Liu, Xia Wang, 2021, BMC cancer.

Cell Biology International

Jiong Cai, Anwen Liu, Zhimin Zeng, 2020 .

Characteristics and outcomes of primary pleural angiosarcoma

Jiong Cai, Anwen Liu, Xia Wang, 2022, Medicine.

PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse model.

Daya Luo, Anwen Liu, Zhimin Zeng, 2022, International immunopharmacology.

EGFR (p. G719A+L747V)/EML4-ALK Co-alterations in Lung Adenocarcinoma with Leptomeningeal Metastasis Responding to Afatinib Treatment: A Case Report

Jiong Cai, Anwen Liu, Q. Xiong, 2021, OncoTargets and therapy.

OTT_A_294635 2823..2828

Jiong Cai, Anwen Liu, Q. Xiong, 2021 .

Two different patients with pulmonary pleomorphic carcinoma response to PD-1 inhibitor plus anlotinib.

Anwen Liu, Zhimin Zeng, Jianping Wei, 2021, Lung cancer.

Positive association between heart dosimetry parameters and a novel cardiac biomarker, solubleST‐2, in thoracic cancer chest radiation

Long Huang, Zhimin Zeng, Jing Cai, 2020, Journal of clinical laboratory analysis.